Company intelligence / Profile preview

Bioventus

Durham, North Carolina, United Statesbioventus.com ↗
Ownership
Public · BVS
Employees
~1200
Development stage
Other
01

Overview

Bioventus markets a broad portfolio of commercial-stage products in three main segments—Pain Treatments, Restorative Therapies, and Surgical Solutions. Its key offerings include the StimRouter PNS system for chronic peripheral nerve pain; EXOGEN Ultrasound Bone Healing System for fracture repair; hyaluronic acid-based joint injection therapies; and a comprehensive suite of surgical orthobiologic bone graft solutions. The company’s products are supported by clinical data demonstrating efficacy in improving mobility and reducing the need for invasive procedures.

Therapeutic areas
RheumatologyNeurologyOther
Modalities
DeviceBiologicUltrasound-based therapySmall moleculeNeuromodulation device
Industry
Biotech
02

Drug pipeline

4 assets

nasha hyaluronic acid

Unknown

3 more assets in the full pipeline.

Request access →
03

Partnerships

Distribution agreements with healthcare organizations globally
04

Financials

Market cap
$923.4M
Total revenue
$153.2M
Enterprise value
$1.2B

Beyond the preview

Go deeper on Bioventus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioventus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call